Back to Search Start Over

SARS-CoV-2 infection in pediatric population.

Authors :
Manti S
Licari A
Montagna L
Votto M
Leonardi S
Brambilla I
Castagnoli R
Foiadelli T
Marseglia GL
Cardinale F
Caffarelli C
Tosca MA
Cravidi C
Duse M
Chiappini E
Source :
Acta bio-medica : Atenei Parmensis [Acta Biomed] 2020 Sep 15; Vol. 91 (11-S), pp. e2020003. Date of Electronic Publication: 2020 Sep 15.
Publication Year :
2020

Abstract

n December 2019, in Wuhan (Hubei, China), the first COVID-19 cases due to SARS-COV-2 had been reported. On July 1st 2020, more than 10.268.839 million people had developed the disease, with at least 506.064 deaths. At present, Italy is the third country considering the number of cases (n=240.760), after Spain, and the second for the cumulative number of deaths (n=249.271), after the United States. As regard pediatric COVID-19 cases, more than 4000 cases (have been reported; however, these figures are likely to be underestimated since they are influenced by the number of diagnostic tests carried out. Three pediatric deaths have been reported in Italy to date. We aimed to review the peculiar aspects of SARS-COV-2 infection in the pediatric population.

Details

Language :
English
ISSN :
2531-6745
Volume :
91
Issue :
11-S
Database :
MEDLINE
Journal :
Acta bio-medica : Atenei Parmensis
Publication Type :
Academic Journal
Accession number :
33004773
Full Text :
https://doi.org/10.23750/abm.v91i11-S.10298